Artiva Biotherapeutics, Inc.
ARTV
$3.64
$0.061.68%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.62% | -14.22% | -10.50% | 26.46% | 214.96% |
| Total Receivables | -14.66% | 340.17% | -80.37% | -14.92% | -10.25% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.11% | 48.96% | -26.99% | 105.84% | 55.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -13.11% | -12.32% | -9.87% | 25.28% | 202.65% |
|
|
|||||
| Total Current Assets | -13.11% | -12.32% | -9.87% | 25.28% | 202.65% |
| Net Property, Plant & Equipment | -6.89% | -4.61% | 1.76% | -5.04% | -5.39% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 76.15% | 5.27% | -9.71% | -5.58% | -83.78% |
| Total Assets | -12.12% | -11.44% | -8.74% | -7.10% | 197.18% |
|
|
|||||
| Total Accounts Payable | -30.21% | -40.32% | 81.62% | -7.74% | 47.63% |
| Total Accrued Expenses | 20.35% | -8.42% | -13.76% | -11.41% | 34.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -12.90% | -2.10% | -0.53% | 0.19% | -1.50% |
| Total Finance Division Other Current Liabilities | 0.00% | 0.00% | -- | -- | -- |
| Total Other Current Liabilities | 0.00% | 0.00% | -- | -- | -- |
| Total Current Liabilities | 3.26% | -11.77% | -0.40% | -7.82% | 22.77% |
|
|
|||||
| Total Current Liabilities | 3.26% | -11.77% | -0.40% | -7.82% | 22.77% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.09% | -6.75% | -3.18% | -5.53% | -6.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 0.00% | -99.74% |
| Total Liabilities | -3.50% | -9.48% | -2.01% | -6.75% | -51.38% |
|
|
|||||
| Common Stock & APIC | 0.37% | 0.35% | 0.54% | 0.51% | 1,869.25% |
| Retained Earnings | -7.47% | -7.96% | -8.23% | -6.98% | -8.20% |
| Treasury Stock & Other | 4,250.00% | -- | -- | -138.17% | 179.34% |
| Total Common Equity | -13.30% | -11.70% | -9.57% | -7.14% | 205.18% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.30% | -11.70% | -9.57% | -7.14% | 205.18% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.30% | -11.70% | -9.57% | -7.14% | 693.95% |
|
|
|||||